Newsfiscal.ai
DiaMedica Therapeutics Reschedules Fetal Growth Restriction Key Opinion Leader Webinar
· Published
Article summary
DiaMedica Therapeutics has moved its virtual Key Opinion Leader (KOL) event from October 23, 2026, to November 24, 2026, to incorporate preliminary data into the presentation.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…